109 related articles for article (PubMed ID: 3121222)
1. Expression of functional interleukin 2 receptors on chronic lymphocytic leukaemia B lymphocytes is modulated by recombinant interleukin 2.
Murphy JJ; Malkovska V; Hudson L; Millard RE
Clin Exp Immunol; 1987 Oct; 70(1):182-91. PubMed ID: 3121222
[TBL] [Abstract][Full Text] [Related]
2. In vitro maturation of B cells in chronic lymphocytic leukemia. I. Synergistic action of phorbol ester and interleukin 2 in the induction of Tac antigen expression and interleukin 2 responsiveness in leukemic B cells.
Kabelitz D; Pfeffer K; von Steldern D; Bartmann P; Brudler O; Nerl C; Wagner H
J Immunol; 1985 Oct; 135(4):2876-81. PubMed ID: 2993419
[TBL] [Abstract][Full Text] [Related]
3. Direct effect of interleukin 2 on chronic lymphocytic leukaemia B cell functions and morphology.
Malkovska V; Murphy J; Hudson L; Bevan D
Clin Exp Immunol; 1987 Jun; 68(3):677-84. PubMed ID: 3115651
[TBL] [Abstract][Full Text] [Related]
4. Immunoregulatory T-cell defects in B-cell chronic lymphocytic leukemia: cause or consequence of the disease? The contributory role of decreased availability of interleukin 2 (IL-2).
Foa R; Fierro MT; Giovarelli M; Lusso P; Benetton G; Bonferroni M; Forni G
Blood Cells; 1987; 12(2):399-412. PubMed ID: 2887225
[TBL] [Abstract][Full Text] [Related]
5. Heterogeneity of responsiveness of chronic lymphocytic leukemic B cells to B cell growth factor or interleukin 2.
Hivroz C; Grillot-Courvalin C; Brouet JC; Seligmann M
Eur J Immunol; 1986 Aug; 16(8):1001-4. PubMed ID: 3488907
[TBL] [Abstract][Full Text] [Related]
6. Role of the interleukin 2 receptor in differentiation of a clone of Ly-1+ B cells.
Bishop GA; Haughton G
J Immunol; 1987 May; 138(10):3308-13. PubMed ID: 3106480
[TBL] [Abstract][Full Text] [Related]
7. Malignant chronic lymphocytic leukemia B cells express interleukin 2 receptors but fail to respond to interleukin 2's proliferative signal.
Perri RT; Kay NE
Leukemia; 1987 Feb; 1(2):127-30. PubMed ID: 3118104
[TBL] [Abstract][Full Text] [Related]
8. Normal and certain leukaemic B cells express IL-2 receptors without in vitro activation.
Armitage RJ; Cawley JC
Clin Exp Immunol; 1986 Feb; 63(2):298-302. PubMed ID: 3009062
[TBL] [Abstract][Full Text] [Related]
9. Structure/function analyses of IL-2 binding proteins on human B cell precursor acute lymphoblastic leukemias.
Wörmann B; Anderson JM; Ling ZD; LeBien TW
Leukemia; 1987 Sep; 1(9):660-6. PubMed ID: 3118114
[TBL] [Abstract][Full Text] [Related]
10. Effect of IL-2R beta-binding cytokines on costimulatory properties of chronic lymphocytic leukaemia cells: implications for immunotherapy.
Spaner DE; Hammond C; Mena J; Shi Y
Br J Haematol; 2004 Dec; 127(5):531-42. PubMed ID: 15566356
[TBL] [Abstract][Full Text] [Related]
11. IL-13 has only a subset of IL-4-like activities on B chronic lymphocytic leukaemia cells.
Fluckiger AC; Brière F; Zurawski G; Bridon JM; Banchereau J
Immunology; 1994 Nov; 83(3):397-403. PubMed ID: 7530690
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibody OKT11A inhibits and recombinant interleukin 2 (IL 2) augments expression of IL 2 receptors at a pretranslational level.
Reed JC; Greene WC; Hoover RG; Nowell PC
J Immunol; 1985 Oct; 135(4):2478-82. PubMed ID: 3928749
[TBL] [Abstract][Full Text] [Related]
13. Characterization of interleukin 2 receptors on B-cell chronic lymphocytic leukemia cells.
Tsilivakos V; Tsapis A; Kakolyris S; Iliakis P; Perraki M; Georgoulias V
Leukemia; 1994 Sep; 8(9):1571-8. PubMed ID: 8090033
[TBL] [Abstract][Full Text] [Related]
14. Release of interleukin-6 in cultured B-chronic lymphocytic leukaemia cells is associated with both activation and cell death via apoptosis.
Büssing A; Stein GM; Stumpf C; Schietzel M
Anticancer Res; 1999; 19(5B):3953-9. PubMed ID: 10628337
[TBL] [Abstract][Full Text] [Related]
15. Idiotypic immunoglobulin secretion by human B cell non-Hodgkin's lymphomas is related to the expression of the interleukin-2 receptor.
Vyth-Dreese FA; Dellemijn TA; Hekman A; Melief CJ
Leukemia; 1988 Apr; 2(4):231-5. PubMed ID: 3129622
[TBL] [Abstract][Full Text] [Related]
16. [Interleukin 2 receptor positive B cells and its responsiveness to human recombinant interleukin 2 in patients with systemic lupus erythematosus].
Matsumoto Y; Itoh A
Rinsho Byori; 1987 Jun; 35(6):679-83. PubMed ID: 3118081
[No Abstract] [Full Text] [Related]
17. Diminished DNA synthesis in T cells from B chronic lymphocytic leukemia after phytohemagglutinin, anti-CD3, and phorbol myristate acetate mitogenic signals.
Prieto A; Garcia-Suarez J; Reyes E; Lapeña P; Hernandez M; Alvarez-Mon M
Exp Hematol; 1993 Nov; 21(12):1563-9. PubMed ID: 8405237
[TBL] [Abstract][Full Text] [Related]
18. Expression and possible function of IL-2 and IL-15 receptors on human uveal melanoma cells.
He YG; Mayhew E; Mellon J; Niederkorn JY
Invest Ophthalmol Vis Sci; 2004 Dec; 45(12):4240-6. PubMed ID: 15557426
[TBL] [Abstract][Full Text] [Related]
19. Analysis and isolation of leukaemic and residual normal B lymphocyte populations from patients with chronic lymphocytic leukaemia.
Murphy JJ; Tooze J; Millard RE; Hudson L
Clin Exp Immunol; 1987 Jun; 68(3):669-76. PubMed ID: 3115650
[TBL] [Abstract][Full Text] [Related]
20. Expression of inhibitory receptor ILT3 on neoplastic B cells is associated with lymphoid tissue involvement in chronic lymphocytic leukemia.
Colovai AI; Tsao L; Wang S; Lin H; Wang C; Seki T; Fisher JG; Menes M; Bhagat G; Alobeid B; Suciu-Foca N
Cytometry B Clin Cytom; 2007 Sep; 72(5):354-62. PubMed ID: 17266150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
